Ami Organics Ltd. (AMIORG) AI Stock Analysis

• Market Cap: ₹114.66B
• Dividend Yield: 0.11%
• Average Volume (3M): 13.90K
• Price to Earnings (P/E): 60.6
• Beta (1Y): 1.07
• Revenue Growth: 40.11%
• EPS Growth: 365.60%
• Country: IN
• Employees: 676
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 5.40
• Shares Outstanding: 81,868,920
• 10 Day Avg. Volume: 12,018
• 30 Day Avg. Volume: 13,901
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,459.00
• Price Target Upside: -0.56% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 70 Neutral
• Price Target: ₹1,459.00 ▼(-0.56% Downside)

Ami Organics Ltd. benefits from strong financial performance and positive technical momentum. However, the stock's high P/E ratio suggests overvaluation, which, combined with potential overbought technical indicators, could introduce short-term risks. Despite strong fundamentals, the negative cash flow and low dividend yield are areas of concern.

Ami Organics Ltd. Business Overview & Revenue Model

Company Description

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India. The company offers approximately 450 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-parkinson, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides preservatives, such as parabens and parabens formulations for use in cosmetics, animal food, and personal care industries; and specialty chemicals for use in cosmetics, dyes, polymers, and agrochemicals. In addition, the company exports its products. Ami Organics Limited was founded in 2004 and is based in Surat, India.

How the Company Makes Money

Ami Organics Ltd. generates revenue through the manufacturing and sale of specialty chemicals, focusing on pharmaceutical intermediates and APIs. The company supplies these products to pharmaceutical companies, which use them in the development and production of medications. Revenue streams also come from the agrochemical sector, where Ami Organics provides chemicals used in the formulation of pesticides and herbicides. Strategic partnerships with major pharmaceutical and chemical companies enhance its revenue potential. The company benefits from long-term supply agreements, ensuring a steady demand for its products. Additionally, ongoing research and development efforts enable Ami Organics to innovate and expand its product offerings, contributing to its financial growth.

Ami Organics Ltd. Financial Statement Overview

Summary

Ami Organics Ltd. displays strong financial performance with significant revenue and profit growth, operational efficiency, and a robust balance sheet with minimal debt. However, cash flow management remains a concern due to negative free cash flow from high capital expenditures.

Income Statement

Ami Organics Ltd. demonstrates strong revenue growth with a 40.3% increase from 2024 to 2025. The net profit margin improved significantly to 15.8% in 2025, reflecting better profitability. The gross profit margin increased to 45.2%, indicating efficient production and cost management. The EBIT margin of 36.8% also highlights operational efficiency. However, the EBITDA margin decreased slightly to 23.0%, suggesting potential cost pressures in non-operating expenses.

Balance Sheet

The company has a robust balance sheet with a low debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. The equity ratio is strong at 84.5%, reflecting a solid equity base. Return on equity is healthy at 12.1%, driven by increased net income. The company's assets are well-funded by equity, reducing financial risk.

Cash Flow

Ami Organics Ltd. shows a decrease in free cash flow, which remains negative at -763 million in 2025, indicating challenges in generating surplus cash. However, the operating cash flow to net income ratio is positive at 0.75, highlighting adequate cash generation from operations. Free cash flow to net income remains negative, pointing to high capital expenditures impacting liquidity.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2022	Dec 2022	Dec 2021
Income Statement
Total Revenue	10.07B	10.07B	7.17B	5.18B	6.17B	3.41B
Gross Profit	4.03B	4.55B	2.63B	1.94B	2.86B	1.22B
EBITDA	2.43B	2.32B	1.04B	1.08B	1.27B	811.14M
Net Income	1.59B	1.59B	427.73M	719.46M	832.90M	539.99M
Balance Sheet
Total Assets	15.49B	15.49B	10.96B	6.59B	7.67B	4.13B
Cash, Cash Equivalents and Short-Term Investments	2.49B	2.49B	533.12M	615.46M	586.70M	26.85M
Total Debt	129.39M	129.39M	2.17B	8.44M	36.00M	1.37B
Total Liabilities	2.29B	2.29B	4.13B	1.37B	1.73B	2.46B
Stockholders Equity	13.10B	13.10B	6.74B	5.22B	5.94B	1.67B
Cash Flow
Free Cash Flow	0.00	-763.00M	-1.56B	-424.18M	-308.73M	-794.33M
Operating Cash Flow	0.00	1.18B	1.25B	-86.60M	655.30M	271.45M
Investing Cash Flow	0.00	-2.24B	-3.68B	-1.24B	-330.44M	-1.00B
Financing Cash Flow	0.00	2.61B	2.39B	1.40B	-122.50M	721.08M

Ami Organics Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1467.25
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AMIORG, the sentiment is Positive. The current price of 1467.25 is above the 20-day moving average (MA) of 1421.09, above the 50-day MA of 1386.06, and above the 200-day MA of 1194.89, indicating a bullish trend. The MACD of 0.11 indicates Positive momentum. The RSI at 54.00 is Neutral, neither overbought nor oversold. The STOCH value of 74.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:AMIORG.

Ami Organics Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMIORG	70 Neutral	₹114.66B	60.64	―	0.11%	40.11%	365.60%
HEG	65 Neutral	₹103.49B	52.58	―	0.34%	-3.91%	0.63%
ALKYLAMINE	62 Neutral	₹94.05B	50.38	―	0.54%	10.29%	26.09%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ANURAS	59 Neutral	₹126.14B	98.64	―	0.07%	24.37%	29.82%
BALAMINES	59 Neutral	₹44.13B	28.99	―	0.80%	-12.28%	-22.10%
RALLIS	59 Neutral	₹58.32B	33.91	―	0.83%	7.10%	29.32%